Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18403247 | 1.00 | KMT2A (0.40) | KMT2AL3MBTL1NAAAMEN1CYP1A2 | |
| SCHEMBL16865259 | 0.92 | OPRK1 (0.33) | KMT2AL3MBTL1 | |
| SCHEMBL18403248 | 0.84 | KMT2A (0.41) | KMT2AL3MBTL1NAAA | |
| SCHEMBL16865287 | 0.84 | KMT2A (0.41) | KMT2AL3MBTL1NAAA | |
| SCHEMBL16865268 | 0.84 | KMT2A (0.41) | KMT2AL3MBTL1NAAABACE1 | |
| SCHEMBL17245217 | 0.84 | KMT2A (0.45) | KMT2AL3MBTL1NAAA | |
| SCHEMBL16865261 | 0.84 | KMT2A (0.41) | KMT2AL3MBTL1NAAABACE1 | |
| SCHEMBL16604080 | 0.83 | KMT2A (0.38) | KMT2AL3MBTL1NAAAKDM1AMAOB | |
| SCHEMBL16865246 | 0.83 | KMT2A (0.38) | KMT2AL3MBTL1NAAAKDM1AMAOB | |
| SCHEMBL16864930 | 0.82 | KMT2A (0.39) | KMT2AL3MBTL1KDM1AMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9549555-B2 | Macrocyclic picolinamide compounds with fungicidal activity | DOW AGROSCIENCES LLC (US) | 2017-01-24 | — | — | US | disclosed |
| US-9549555-B2 | Macrocyclic picolinamide compounds with fungicidal activity | DOW AGROSCIENCES LLC (US) | 2017-01-24 | — | — | US | disclosed |
| US-9247741-B2 | Use of macrocyclic picolinamides as fungicides | DOW AGROSCIENCES LLC (US) | 2016-02-02 | — | — | US | disclosed |
| US-9247741-B2 | Use of macrocyclic picolinamides as fungicides | DOW AGROSCIENCES LLC (US) | 2016-02-02 | — | — | US | disclosed |
| US-20150183759-A1 | MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY | DOW AGROSCIENCES LLC | 2015-07-02 | — | — | US | disclosed |
| US-20150181867-A1 | USE OF MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | DOW AGROSCIENCES LLC | 2015-07-02 | — | — | US | disclosed |
| US-20150181867-A1 | USE OF MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | DOW AGROSCIENCES LLC | 2015-07-02 | — | — | US | disclosed |
| US-20150183759-A1 | MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY | DOW AGROSCIENCES LLC | 2015-07-02 | — | — | US | disclosed |
| WO-2015100182-A1 | USE OF MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | DOW AGROSCIENCES LLC (US) | 2015-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150183759-A1 | MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY | CYP51A1, PFAS, AADAC | KMT2A 2871/4885L3MBTL1 4494/4885NAAA 587/4885 |
| US-20150181867-A1 | USE OF MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | FKBP14, CYP4F12, CYP1A2 | KMT2A 3287/4885L3MBTL1 4382/4885NAAA 1708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.